Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Cotra Enterprises Sdn. Bhd. | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Irritable bowel syndrome (IBS) is frequently associated with any form of psychiatric comorbidities including subthreshold or subclinical depression. Modification of gut ecology with probiotics has implicitly improved IBS and depressive symptoms. However, the efficacy of probiotics on IBS with existing subthreshold depression remain elusive. Therefore, the aim of this study is to evaluate the effects of lactobacillus-containing cultured milk drink on depression scores in adults diagnosed with IBS.
A total of 140 subjects who fulfilled Rome IV criteria for IBS will be recruited from a tertiary medical centre and among public volunteers. The depression status and categories will be assessed using the Centre Epidemiologic Studies Depression Scale Revised questionnaire (CESD-R): normal mood (score<16), or subthreshold depression (score>16). The subjects are randomised and blinded into four groups: Group A (Normal mood with placebo, n=35), Group B (Normal mood with probiotics, n=35), Group C (Subthreshold depression with placebo, n=35) and Group D (Subthreshold depression with probiotics, n=35). The subjects will be instructed to consume two bottles of cultured milk drink daily for 12 weeks. The probiotic cultured milk drinks contained 10^9 cfu L. CASEI-01 and LA-5. The severity of depression will be measured using Patient Health Questionnaire (PHQ-9) at pre- and post-12-week intervention. Secondary outcome on IBS symptoms severity will be assessed with IBS Symptoms Severity Score (IBS-SSS) and IBS Quality of Life (IBS-QOL).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Irritable bowel syndrome with normal mood receiving placebo | Placebo Comparator | A total of 35 patients diagnosed with IBS as per Rome IV criteria who scored CESD-R less than 16 will be supplemented with placebo drinks. |
|
| Irritable bowel syndrome with normal mood receiving probiotics | Active Comparator | A total of 35 patients diagnosed with IBS as per Rome IV criteria who scored CESD-R less than 16 will be given lactobacillus-containing cultured milk drinks. |
|
| Irritable bowel syndrome with subthreshold depression receiving placebo | Placebo Comparator | A total of 35 patients diagnosed with IBS as per Rome IV criteria who scored CESD-R of 16 or above will be supplemented with placebo drinks. |
|
| Irritable bowel syndrome with subthreshold depression receiving probiotics | Experimental | A total of 35 patients diagnosed with IBS as per Rome IV criteria who scored CESD-R of 16 or above will be given lactobacillus-containing cultured milk drinks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Lactobacillus containing cultured milk drink | Dietary Supplement | Each bottle of 125ml cultured milk drink contains a billion colony forming unit (CFU) Lactobacillus acidophillus (LA-5) and Lactobacillus paracasei (L. CASEI-01). Each patient will be given 2 bottles to consume daily for a period of 12 weeks. |
| Measure | Description | Time Frame |
|---|---|---|
| Depression score | The Centre for Epidemiologic Studies Depression Scale Revised Version (CESD-R) will be used to classify the patients according to their depression status. | 12 weeks |
| Depression severity scale | The Patient Health Questionnaire-9 (PHQ-9) will be used to assess the severity scale for the patients. | 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of life score | The life quality of patients will be measured using the Irritable bowel syndrome Quality of Life Questionnaire (IBS-QOL). | 12 weeks |
| IBS severity score | Any changes in gastrointestinal symptoms severity related to IBS will be quantify using the Irritable bowel syndrome Severity Scoring System (IBS-SSS). |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Prof. Dr. Norfilza Mohd Mokhtar | Contact | +60391458424 | norfilza@ppukm.ukm.edu.my | |
| Prof. Dr. Raja Affendi Raja Ali | Contact | +60391455022 | draffendi@ppukm.ukm.edu.my |
| Name | Affiliation | Role |
|---|---|---|
| Prof. Dr. Raja Affendi Raja Ali | Gastroenterology Unit, Faculty of Medicine, Universiti Kebangsaan Malaysia, Malaysia | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Universiti Kebangsaan Malaysia | Recruiting | Bandar Tun Razak | Kuala Lumpur | 56000 | Malaysia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a randomized and parallel study involving patients with IBS who attended gastroenterology clinics at Universiti Kebangsaan Malaysia Medical Center (UKMMC). The recruited subjects will be categorized according to their CESD-R scores and randomly allocated into receiving either placebo or probiotic-containing cultured milk drink for 12 weeks.
Not provided
Not provided
Both investigators and subjects will be blinded to the treatment products.
|
| Placebo cultured milk drink | Dietary Supplement | The placebo prepared was identical to the probiotic-containing product in terms of color, taste and packaging. However, there is no trace of live microorganism in this product. |
|
| 12 weeks |
| Acute stress biomarker | Morning blood sample will be collected to measure serum cortisol level among patients with IBS. | 12 weeks |
| Depression biomarker | Blood samples collected will be analysed to measure the serum serotonin level of patients with IBS. | 12 weeks |
| ID | Term |
|---|---|
| D043183 | Irritable Bowel Syndrome |
| ID | Term |
|---|---|
| D003109 | Colonic Diseases, Functional |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided